The Biden administration released initial draft guidance on Monday seeking public comment on provisions of the Inflation Reduction Act that allow Medicare prescription drug plan enrollees to pay out-of-pocket drug costs in monthly installments throughout the plan year beginning in 2025.
The draft guidance from the Centers for Medicare & Medicaid Services are designed to help Medicare “Part D” prescription drug plans and pharmacies prepare for the payment plan option with information on: identifying beneficiaries likely to benefit from the new program, how prescription drug plan enrollees can utilize the program, consumer protections for participating enrollees, and the type of ...